The EUA allows for Remdesivir to be distributed in the US and administered intravenously by health care providers, as appropriate, to treat suspected or laboratory-confirmed COVID-19 in adults and children hospitalised with severe condition.
'There is no emergency of a third wave that we are rushing for booster doses.'
Niclosamide, a drug on the World Health Organisation's list of essential medicines, has been used to treat tapeworm infestation for more than 50 years. The oral antiviral drug was also used to treat patients during the SARS outbreak of 2003-04.
The New York Times on Tuesday said Covaxin works by teaching the immune system to make antibodies against the SARS-CoV-2 coronavirus. The antibodies attach to viral proteins, such as the so-called spike proteins that stud its surface.
According to SOP, those testing positive will be isolated in a separate unit of an institutional facility.
For Yoginder, it is a release from pain. But for us, his friends, it is the loss of a warm and generous life companion, says Nitin Desai of his 50-year association with the eminent economist who passed into the ages on December 6, 2022.
The procurement and distribution will be centralised though the government is yet to take a call on the initial number of doses that will be procured.
The percentage of patients with serious infections had halved from previous admissions.
There are a number of vaccine candidates already in clinical trial and a few out of those candidates have completed phase 1/2 status, he said, adding that there are trials that will be going into phase three sometime at the end of July and then others will follow in the months of August, September and October.
The panel was informed that the economic impact of the second wave of viral infection was "asynchronous in its onset and wider in its spread particularly in rural hinterland", a source said.
The novel coronavirus has mutated before, and both companies say they've found that their vaccines worked against other variations of the virus.
All these persons have been kept in single room isolation at designated health care facilities by respective state governments and their close contacts have also been put under quarantine, the ministry said.
'If we go in the same direction as them, we cannot expect a different result from them.' 'Our fall is going to be very swift.' 'Within a decade, we can expect the situation to change for the worse.'
The residents of Delhi stand to lose 10 years of life expectancy if the current air pollution level persists.
The prime minister was happy that the assurance given by the Serum Institute that it will make India self-sufficient in vaccines at the lowest possible price in the world was fulfilled.
A total of 800 people, belonging to 237 families, have so far been shifted to safety by the district administration
Heatwaves claimed more than 17,000 lives in 50 years in India, according to a paper authored by M Rajeevan, former secretary of Ministry of Earth Sciences, along with scientists Kamaljit Ray, S S Ray, R K Giri and A P Dimri.
"We raced against time and were the first country to report cases to the world," Chinese foreign minister Wang Yi said in interviews to the official media over the weekend.
In the midst of third wave of COVID-19, Finance Minister Nirmala Sitharaman has come up with an impactful Budget which is balanced, fiscally prudent and growth-oriented, the USA India Chamber of Commerce has said. President of the Boston-based USA India Chamber of Commerce (USAIC) Karun Rishi, however, said it is a matter of concern that the budget lacks tangible measures to increase revenue generation. "Opting to keep the fiscal deficit at 6.9 per cent and increase capital expenditure by 35 per cent is a masterstroke. "The annual budget estimates the effective capital expenditure of Rs 10.68 lakh crore in 2022-23, making up about 4.1 per cent of the GDP," he said. "A phenomenal increase in the government's capital expenditure is likely to facilitate the expenditures on infrastructure and create jobs.
The female tiger, named Nadia, is believed to be the first known case of an animal infected with COVID-19 in the US. It is suspected that she contracted the virus from a caretaker who was asymptomatic at that time.
The Union health ministry data on Friday said the number of coronavirus cases in India breached the 45 lakh mark while a data released by a national public health institute in the US said the number of infections in the North American country crossed six million as of September 8.
The government's endeavour, she said, is to protect women in this country in collaboration with state governments.
Covaxin is being developed by Bharat Biotech jointly with the Indian Council of Medical Research (ICMR)- National Institute of Virology (NIV). The Phase III human clinical trials of Covaxin began mid-November, targeted to be done in 26,000 volunteers and it is the country's first and only Phase III efficacy study for a COVID-19 vaccine, a press release from the vaccine maker said on Saturday night.
'By the time actual action began, it was already too late.' 'The virus was raging.'
Maharashtra Deputy Chief Minister Ajit Pawar on Thursday said future decisions on COVID-19 SOPs will be taken in consultation with the Union Health Ministry and the state Task Force, amid a difference between the Centre and the state over guidelines for international travellers in the wake of the new variant of SARS-CoV2.
The fact sheet also asked people to inform the vaccinator or a supervising official about their medical condition before taking the vaccine.
Murthy, who currently is the top Indian-American advisor to President-elect Joe Biden on COVID-19, is a potential pick for the post of Secretary of Health and Human Services and Stanford University Professor Arun Majumdar for the post of Secretary of Energy, The Washington Post and Politico said in their reports on Tuesday that mentions a list of potential picks for various Cabinet-level positions in the Biden administration.
In India, Pakistan, China, Bangladesh, Nigeria, Ethiopia, Democratic Republic of the Congo, and Indonesia, more than 50 million persons in each country were estimated to be without handwashing access, according to the study.
'There is no data to show this virus is more deadlier.'
'The deaths of the children in the Gambia would batter India's reputation as the developing world's pharmacy.'
'Make sure your public hospitals work.' 'Don't allow people to go shopping for expensive services; provide them yourself as the government and then charge them very little or nothing at all.'
'Antibodies remain in the blood for at least seven to nine months.'
The Indian government and private firms have stepped up efforts to develop a vaccine to halt the spread of COVID-19 which has claimed over 3,700 lives with more than 1,25,000 cases in the country.
Most of those who tested positive either recently arrived from African countries or were in contact with such people.
The Zika virus has already been found in some mosquitoes taken as samples from Sindhi Camp while few mosquitoes collected from densely populated Shastri Nagar had already been found to be carriers of the virus leading to suspicion they are behind the spread of the infection.
The government is likely to soon reduce the gap between the second dose of Covid-19 vaccine and the precaution dose from the current nine months to six months, official sources said on Wednesday.
So far, less than 1 per cent of the target population of 77 crore in the 18-59 age group have been administered the precaution dose.
The ICMR has approved over 200 labs (both public and private) for COVID-19 testing through-PCR machines.
Bharat Biotech, Serum Institute, Zydus Cadila, Panacea Biotec, Indian Immunologicals, Mynvax and Biological E are among the domestic pharma firms working on the coronavirus vaccines in India.
The phase 3 trial findings indicate that Covaxin induces a robust antibody response with no severe vaccine-related adverse events or deaths reported among the trial participants, the authors of the study said.
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances